The Drug Enforcement Administration’s (DEA’s) Real-Time Communication Synth-Opioids Network (Synth-Opioids) is designed to create opportunities for swift information exchange...
Reports
Report of the National Survey to Assess First Responder Deflection Programs in Response to the Opioid Crisis
Lisa McElhaney / /The Bureau of Justice Assistance's Comprehensive Opioid, Stimulant, and Substance Abuse Program has announced the availability of the Report...
The U.S. Drug Enforcement Administration (DEA) announced on Monday, June 28, 2021, that it is lifting the 14-year moratorium...
Federal Register: Registration Requirements for Narcotic Treatment Programs With Mobile Components
Lisa McElhaney / /The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially...
LAPPA’s Model Law Enforcement Event Deconfliction Act (the Act) is intended to implement procedures across the country to safeguard...
New High Potency Synthetic Opioid N-Pyrrolidino Etonitazene (Etonitazepyne) Linked to Overdoses Across United States
Lisa McElhaney / /The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners...
The EMCDDA also released an update on benzodiazepines this week. As of February 2021, 30 new benzodiazepines were tracked...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released its 2021 drug report. Using data from 29...
Federal Register: Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMBCHMICA, and 5F-CUMYL-P7AICA in Schedule I
Lisa McElhaney / /Schedules of controlled substances: Placement of 5 synthetic cannabinoids into Schedule I
The research, published in the 2021 Drug Diversion Digest, is the only report of its kind to compile and...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024